🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a feasibility study evaluating the use of a mathematical model to p...
Status
Completed
Location
University of New Mexico Comprehensive Cancer Center
Start Date
2015-06-02
Trial ID
NCT03983538
Treatments Being Tested
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested
Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Status
Completed
Location
Guangdong general hospital
Start Date
2018-08-01
Trial ID
NCT03243838
Treatments Being Tested
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
The purpose of this study is to evaluate the efficacy and tolerability of t...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2007-05
Trial ID
NCT00767377
Treatments Being Tested
Investigate the effect of induction MEPFL chemotherapy followed by concurre...
Status
Completed
Location
Kaohsiung Medical University Hospital
Start Date
2003-08
Trial ID
NCT00201396
Treatments Being Tested
The goal of this study is to find the highest tolerated dose of NC-6300 tha...
Status
Unknown
Location
City of Hope National Medical Center
Start Date
2017-06-30
Trial ID
NCT03168061
Treatments Being Tested
A multicenter, prospective, open, randomized cohort, non controlled phase I...
Status
Completed
Location
Jie Ge
Start Date
2023-04-11
Trial ID
NCT06009627
RATIONALE: Drugs used in chemotherapy, such as docetaxel and epirubicin, wo...
Status
Unknown
Location
Centre Paul Papin
Start Date
2001-04
Trial ID
NCT00075465
Treatments Being Tested
Our study is a prospective, non-inferior, randomized phase II clinical tria...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT02838225
Treatments Being Tested